Cargando…
Dietary Supplements in Chemotherapy-Induced Peripheral Neuropathy: A New Hope?
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the main and most prevalent side effects of chemotherapy, significantly affecting the quality of life of patients and the course of chemotherapeutic treatment. Nevertheless, despite its prevalence, the management of the CIPN is considered p...
Autores principales: | Szklener, Katarzyna, Szklener, Sebastian, Michalski, Adam, Żak, Klaudia, Kuryło, Weronika, Rejdak, Konrad, Mańdziuk, Sławomir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8838672/ https://www.ncbi.nlm.nih.gov/pubmed/35276984 http://dx.doi.org/10.3390/nu14030625 |
Ejemplares similares
-
Ibrutinib in the Treatment of Solid Tumors: Current State of Knowledge and Future Directions
por: Szklener, Katarzyna, et al.
Publicado: (2022) -
Ozone in Chemotherapy-Induced Peripheral Neuropathy—Current State of Art, Possibilities, and Perspectives
por: Szklener, Katarzyna, et al.
Publicado: (2023) -
New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors
por: Szklener, Katarzyna, et al.
Publicado: (2022) -
Enhancing glioblastoma treatment through the integration of tumor-treating fields
por: Szklener, Katarzyna, et al.
Publicado: (2023) -
New Directions in the Therapy of Glioblastoma
por: Szklener, Katarzyna, et al.
Publicado: (2022)